This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Resumen de acción MO4
Mediclinic International plc, together with its subsidiaries, operates private hospitals.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Mediclinic International plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£5.72 |
| 52 Week High | UK£5.95 |
| 52 Week Low | UK£4.44 |
| Beta | 0.42 |
| 1 Month Change | 2.33% |
| 3 Month Change | 1.24% |
| 1 Year Change | 28.83% |
| 3 Year Change | 81.13% |
| 5 Year Change | -16.13% |
| Change since IPO | -50.13% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| MO4 | DE Healthcare | Mercado DE | |
|---|---|---|---|
| 7D | 0.3% | 4.1% | -1.5% |
| 1Y | 28.8% | -0.8% | 0.9% |
Rentabilidad vs. Industria: MO4 exceeded the German Healthcare industry which returned -21.5% over the past year.
Rentabilidad vs. Mercado: MO4 exceeded the German Market which returned -8.5% over the past year.
Volatilidad de los precios
| MO4 volatility | |
|---|---|
| MO4 Average Weekly Movement | 1.7% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: MO4 has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: MO4's weekly volatility (2%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Resumen de fundamentos de Mediclinic International plc
| Estadísticas fundamentales de MO4 | |
|---|---|
| Capitalización bursátil | €4.26b |
| Beneficios(TTM) | €194.98m |
| Ingresos (TTM) | €3.90b |
21.9x
Ratio precio-beneficio (PE)1.1x
Ratio precio-ventas (PS)¿Está MO4 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MO4 | |
|---|---|
| Ingresos | UK£3.38b |
| Coste de los ingresos | UK£2.66b |
| Beneficio bruto | UK£728.00m |
| Otros gastos | UK£559.00m |
| Beneficios | UK£169.00m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.23 |
| Margen bruto | 21.52% |
| Margen de beneficio neto | 5.00% |
| Ratio deuda/patrimonio | 54.1% |
¿Cómo se ha desempeñado MO4 a largo plazo?
Ver rendimiento histórico y comparativa